MedPharm DBA Bud & Mary's, a federally licensed cannabis research and pharmaceutical development company, continues to lead scientific advancements in cannabis-based therapeutics as the only U.S.

Tennessee legislators have introduced bicameral legislation that would criminalize producing, selling, and possessing ...

A study published in Scientific Reports found that cannabidiol (CBD) disrupts lipid metabolism and induces apoptosis in ...

As the cannabis industry continues to evolve, consumers are becoming more discerning about quality and innovation in their ...

Widely used substances such as caffeine and cannabinoids were emphasized while intriguing findings on novel compounds, such as Icariin, were also discussed. Importantly, the collection recognizes that ...

The study, published on January 21 in Proceedings of the National Academy of Sciences, focused on three cannabinoids: cannabidiol (CBD), cannabigerol (CBG), and cannabinol (CBN). Unlike THC ...

Centre for Endocrinology, William Harvey Research Institute, Bart’s and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, U.K. School ...

Fatty acids are organic acids with at least one carboxyl (-C(=O)OH, -COOH or -CO2H) group and a long carbon chain that can be joined by double bonds, as in unsaturated fatty acids, or single bonds ...

“These findings open new avenues for the development of cannabinoid-based therapies,” said Mohammad-Reza Ghovanloo, lead author of the study and an associate research scientist in the Department of ...